![]() |
![]() |
My Amedeo
![]() ![]() ![]() |
![]() |
|||||||||
Stroke prevention |
Prostate Cancer |
Free Subscription
1 BJU Int |
Retrieve available abstracts of this week’s articles:
HTML format |
Single Articles |
AMEDEO Prostate Cancer is free of charge.
Prostate-specific antigen for prostate cancer screening.
BJU Int. 2023;131:266.
PubMed
Usefulness of balanced SSFP sequence in robot-assisted MRI-guided prostate
biopsy: Beyond scouting.
Eur J Radiol. 2023;160:110707.
PubMed
Abstract available
A Comprehensive 6-mo Prostate Cancer Patient Empowerment Program Decreases
Psychological Distress Among Men Undergoing Curative Prostate Cancer Treatment: A
Randomized Clinical Trial.
Eur Urol. 2023 Feb 21:S0302-2838(23)02581-2. doi: 10.1016/j.eururo.2023.
PubMed
Abstract available
A Personalised Clinical Dynamic Prediction Model to Characterise Prognosis for
Patients with Localised Prostate Cancer: analysis of the CHHiP Phase III Trial.
Int J Radiat Oncol Biol Phys. 2023 Feb 21:S0360-3016(23)00167.
PubMed
Abstract available
Deep-Learning Models for Detection and Localization of Visible Clinically
Significant Prostate Cancer on Multi-Parametric MRI.
J Magn Reson Imaging. 2023 Feb 24. doi: 10.1002/jmri.28608.
PubMed
Abstract available
[Corrigendum] miR‑195 inhibits cell proliferation and angiogenesis in human
prostate cancer by downregulating PRR11 expression.
Oncol Rep. 2023;49:70.
PubMed
Abstract available
Adaptive and non-adaptive gene expression responses in prostate cancer during
androgen deprivation.
PLoS One. 2023;18:e0281645.
PubMed
Abstract available
Factors impacting on sexual function among men on active surveillance for
prostate cancer.
Prostate. 2023 Feb 24. doi: 10.1002/pros.24502.
PubMed
Abstract available
hSSB1 (NABP2/OBFC2B) modulates the DNA damage and androgen-induced
transcriptional response in prostate cancer.
Prostate. 2023 Feb 22. doi: 10.1002/pros.24496.
PubMed
Abstract available
Thank you for your interest in scientific medicine.
This policy is made possible thanks to
a media sponsorship by